Cellebrite DI (CLBT) Receivables - Other (2020 - 2025)

Cellebrite DI's Receivables - Other history runs 6 years deep, the most recent figure standing at $78.6 million for Q4 2025.

• On a quarterly basis, Receivables - Other fell 3.41% year-over-year to $78.6 million in Q4 2025; TTM through Dec 2025 was $78.6 million, a 3.41% decrease from a year earlier, with the FY2025 full-year figure at $78.6 million, down 3.41% from the prior year.
• Receivables - Other fell to $78.6 million in Q4 2025 per CLBT's latest filing, from $81.3 million in the prior quarter.
• Across five years, Receivables - Other topped out at $89.2 million in Q4 2023 and bottomed at $72.3 million in Q4 2021.
• The 5-year median for Receivables - Other is $81.3 million (2024), against an average of $80.6 million.
• Across the five-year window, Receivables - Other surged 113.13% in 2021 and dropped 8.78% in 2024, its largest moves.
• Year by year, Receivables - Other stood at $72.3 million in 2021, then grew by 12.83% to $81.5 million in 2022, then advanced by 9.38% to $89.2 million in 2023, then retreated by 8.78% to $81.3 million in 2024, then dropped by 3.41% to $78.6 million in 2025.
• Per Business Quant, the three latest CLBT Receivables - Other figures stand at $78.6 million (Q4 2025), $81.3 million (Q4 2024), and $89.2 million (Q4 2023).